Featured
Last news
Exousia Pro Initiates Strategic Realignment, Acquires Controlling Stake in SEC-Reporter Lamy (LMMY) in All-stock Exchange Transaction for Exousia AI, to Advance Growth and Enhance Shareholder Value
ORLANDO, FLORIDA / ACCESS Newswire / November 17, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based delivery systems, today announced it has completed the initial stage of a strategic realignment by acquiring a controlling interest in LAMY, an SEC-reporting company (OTCID:LMMY), in exchange for Exousia Pro's subsidiary, Exousia AI, Inc., in an all-stock transaction. Exousia Pro received approximately 51% of LMMY restricted Common Stock, positioning MAJI as the controlling shareholder of LMMY.
D.C. Circuit Grills DEA Over Years Long Delays as MMJ BioPharma Cultivation Demands Timely Ruling on Cannabis Grow
From Iowaska Church to MMJ BioPharma Cultivation, Appellate Courts Patience with DEA's Inaction Wears Thin Amid Constitutional Challenges.Administrator Terrance "Terry" Cole must issue a final order "as soon as practicable." The Administrative Procedure Act likewise requires agencies to "proceed to conclude a matter presented to [them]" within a reasonable time.
MEDevice Silicon Valley 2025 Keynotes to Feature Visionary MedTech Leaders
SANTA CLARA, CA / ACCESS Newswire / November 17, 2025 / MEDevice Silicon Valley 2025 (November 19-20, Santa Clara Convention Center) is set to deliver keynote presentations featuring visionary MedTech leaders who will discuss the latest developments in artificial intelligence, robotics, digital health and innovation.
Avrio Announces the Appointment of James O'Neill as Chief Investment Officer to Lead Global Investment and Capital Markets Strategy
NEW YORK, NY, LONDON, UK, and ABU DHABI, UAE /ACCESS Newswire / November 17, 2025 / Avrio Worldwide PBC ("Avrio"), a global financial services technology company providing institutional-grade market infrastructure, services, and data across public, private, and digital markets, today announced the appointment of James O'Neill as Chief Investment Officer (CIO).
Compassion Center, the Las Vegas Community, and Loved Ones Honor the Life and Immeasurable Legacy of Julie "Nurse Juhlzie" Monteiro with Community Celebrations December 13-14, 2025
It is with the greatest of sadness and the deepest of regret that Compassion Center announces the passing of its most beloved, precious, fearless, and courageous leader, Julie "Nurse Juhlzie" Monteiro (Creel), who peacefully transitioned of natural causes on November 11th, 2025, in the comfort, warmth, and sanctuary of her cozy king-sized bed.
VSEE Health, Inc. Delivers Robust Q3 2025 Revenue Growth Amid Telehealth Expansion: Total Revenues Reach $3.98 Million, Up 19% Year-Over-Year
SAN JOSE, CALIFORNIA / ACCESS Newswire / November 17, 2025 / VSee Health, Inc. (Nasdaq:VSEE), a pioneering provider of AI-powered telehealth solutions and high-acuity virtual care services, today announced its financial results for the third quarter ended September 30, 2025, as detailed in its Form 10-Q filed with the SEC on November 14, 2025.
CNS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Cash expected to fund operations into the second half of 2026Company focused on advancing next-generation anti-cancer therapies derived from well-established drug classes, now engineered to cross the blood-brain barrier, potentially enhancing efficacy for patientsLead program, TPI 287, progressing toward Phase 2 study for treatment of glioblastoma multiforme (GBM), one of the most aggressive types of brain cancer, with a median survival of only around 15 months from the time of diagnosis
Kultura Brands (OTC:LTNC) Announces Official Launch Elevate Health & Wellness Gummies
KULTURA BRANDS (OTCID: LTNC) ANNOUNCES OFFICIAL LAUNCH ELEVATE HEALTH & WELLNESS GUMMIES NOW AVAILABLE FOR B2B THROUGH CENCORA MARKETPLACE AND DIRECT-TO-CONSUMER AT LOCKDIN.COM; THIRST RESPONDER HYDRATION LAUNCHES MID-DECEMBER; PORTION OF ALL SALES BENEFITS THE MANNY PACQUIAO FOUNDATION
NanoViricides, Inc. Has Filed its Quarterly Report - Subsequent Raise Has Fortified Fiscal Position
SHELTON, CONNECTICUT / ACCESS Newswire / November 17, 2025 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), reports that it has filed its Quarterly Report on Form 10-Q for the fiscal quarter ending September 30, 2025 with the Securities and Exchange Commission (SEC) on Friday, November 14, 2025. The report can be accessed at the SEC website (https://www.sec.gov/Archives/edgar/data/1379006/000110465925112608/nnvc-20250930x10q.htm).
Modular Medical Receives IRB Approval to Deliver Insulin Using Pivot Patch Pump
Study to Deliver Insulin to Internal Testers Wearing Continuous Glucose Monitors
Ensysce Biosciences Secures $4 Million Financing, Unlocking Up to $20 Million in Total Financing to Advance Breakthrough Pain Programs
~Funding supports Phase 3 clinical development of PF614 and continued innovation in abuse- and overdose-resistant analgesics~
Jaguar Health Reports Third Quarter 2025 Financials: Net Q3 2025 Revenue Up Approximately 4% Versus Net Q2 2025 Revenue
Initial results of ongoing investigator-initiated proof-of-concept trial demonstrate crofelemer can potentially extend the lives of infants born with intestinal failure due to microvillus inclusion disease (MVID), reducing the volume of the total parenteral support (PS) necessary for them to survive, though with associated toxicity; Groundbreaking PS reduction of up to 37%; No approved treatments exist for MVIDCompany completed meeting with FDA October 2, 2025 for advice on possible expedited approval pathway to advance its ongoing placebo-controlled trial of crofelemer for potential approval for treatment of MVIDREMINDER: Today Jaguar to host investor webcast at 8:30 a.m. Eastern regarding Q3 2025 financials and company updates; Click here to register
Medicus Pharma Ltd. Announces Filing of FDA Commissioner's National Priority Voucher Application (CNPV) for SKNJCT-003 to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
SKNJCT-003 Doxorubicin containing Microneedle Array (D-MNA) clinical development program to non-invasively treat BCC aligns with national priorities of public health impact, unmet medical need, access, affordability, domestic manufacturing and rare-disease alignment.
Organto Foods Inc. Announces Prepayment of Convertible Notes
Optimizes Capital Structure and Financial Flexibility
OBI-902 Has Been Granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma
OBI-902 is the first ADC utilizing OBI's proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer.
Wellgistics Health to Report Third Quarter 2025 Financial Results and Provide a Business Update on the morning of Thursday, November 20th, 2025
TAMPA, FL / ACCESS Newswire / November 17, 2025 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a health information technology leader at the nexus of the physical and technology healthcare infrastructures for prescription drug distribution from manufacturer to patient through licensed pharmacies, today announced that it will report third quarter 2025 provide a business update and report financial results for the period ended September 30, 2025 on the morning of Thursday, November 20, 2025.
Ex-abbot of China's Shaolin Temple arrested for embezzlement
The former head of the Chinese temple known as the birthplace of kung fu has been arrested over suspicion of embezzlement, local authorities said Sunday.
President Trumps Cannabis Decision Soon: From Hemp Shutdown to Pharmaceutical Clarity: MMJ Leads Federally Legal Cannabis Drug Development
"The federal hemp crackdown has created long overdue pharmaceutical clarity. MMJ is now the company advancing a fully compliant cannabinoid drug program under FDA and DEA oversight," noted Duane Boise, CEO MMJ International Holdings. "Drug development allows for no shortcuts. It demands consistency, validation, and adherence to federal law."
Doha Tattoo Festival Announced as Ticket Sales Officially Open
DOHA, QA / ACCESS Newswire / November 16, 2025 / Under the patronage of His Excellency Sheikh Khalifa bin Hamad bin Khalifa Al Thani, Minister of Interior and Commander of the Internal Security Force (Lekhwiya), the first edition of the Doha International Music and Marching Festival (Doha Tattoo) will be held from 16 to 20 December 2025 at Katara Cultural Village.
Huge fire sparked by explosions near Argentine capital 'contained'
A large blaze ignited by powerful explosions at an industrial park near Argentina's capital has been contained, local authorities reported on Saturday.
Huge explosions rock industrial area near Argentina's capital
Powerful explosions tore through an industrial park near Argentina's capital on Friday, sparking a huge blaze and injuring more than 20 people.
Nine killed in accidental explosion at Indian Kashmir police station
Nine people were killed and 31 injured when confiscated explosives accidentally blew up at a police station in Indian-administered Kashmir, police said Saturday, just days after a car blast in Delhi killed a dozen people.
EU bows to pressure on loosening AI, privacy rules
The European Union is set next week to kickstart a rollback of landmark rules on artificial intelligence and data protection that face powerful pushback on both sides of the Atlantic.
Purdue Pharma to be dissolved as US judge says to approve bankruptcy
OxyContin maker Purdue Pharma, blamed for helping to fuel a deadly opioid crisis, said Friday that a US bankruptcy judge will sign off on a deal to settle thousands of lawsuits against the company, which will cease to exist.
New to The Street Airs Landmark Show #700 Today at 6:30 PM ET on Bloomberg Television
Featured companies include Lionscrest Advisors, DataVault AI (NASDAQ:DVLT), Pudgy Penguins (PENGU)), Peer To Peer Network (OTC:PTOP), and Acurx Pharmaceuticals (NASDAQ:ACXP).
Trump demands probe into Epstein links to Bill Clinton
US President Donald Trump said Friday he wants the Justice Department and FBI to investigate links between the late alleged sex trafficker Jeffrey Epstein and former Democratic president Bill Clinton.
UN rights council orders probe of atrocities in Sudan's El-Fasher
The UN Human Rights Council on Friday ordered investigators to probe alleged atrocities in Sudan's El-Fasher and to seek to identify perpetrators so they can be brought to justice.
Thais navigate flooded homes and ancient temples by boat
For three months, Thai retiree Somkid Kijniyom has been sleeping in a small boat surviving on dry food handouts in the waist-high floodwaters that have filled his home.
Second brother of French anti-drugs activist murdered: prosecutor
A gunman on a motorbike has shot dead the 20-year-old youngest brother of a prominent anti-drug activist in the southern French city of Marseille in a possible warning over his campaigning, a prosecutor said on Friday.
BHP liable for 2015 Brazil mine disaster: UK court
A British court ruled Friday that Australian mining giant BHP is liable for one of Brazil's worst environmental disasters, potentially paving the way for billions of pounds in compensation.
What we know about deadly Delhi car blast
India has vowed to bring to justice the "perpetrators, their collaborators, and their sponsors" behind the deadliest explosion in the nation's capital for more than a decade.
Peru's interim president embraces the spotlight in 'war' on crime
Like a veritable action hero, Peru's interim president rolls up his sleeves to take part in nighttime raids on prisons and in the street, always making sure his bravado is captured on camera.